Dr. Michael Shy, MD

• Neurology

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• Albany Medical College

  Medical School, 2005

• Mitochondrial Phenotypes in Genetically Diverse Neurodegenerative Diseases and Their Response to Mitofusin Activation, 2022-03-21

• Mutations in BAG3 Cause Adult Onset Charcot-Marie-Tooth Disease, 2017-07-28

• Reliability of the Charcot-Marie-Tooth Functional Outcome Measure (CMT-FOM), 2020-08-26

• Substrate interaction defects in histidyl-tRNA synthetase linked to dominant axonal peripheral neuropathy, 2017-12-26

• Inherited Peripheral Neuropathies, 2013-03-05

• Carpal Tunnel Syndrome in Inherited Neuropathies: A Retrospective Survey, 2017-07-21

• Charcot-Marie-Tooth neuropathy score and ambulation index are both predictors of orthotic need for patients with CMT, 2021-10-06

• The Charcot Marie Tooth Health Index: Evaluation of a Patient Reported Outcome, 2018-08-29

• Natural history of Charcot-Marie-Tooth disease type 2A: a large international multicentre study, 2021-01-08

• A multicentre retrospective study of Charcot-Marie-Tooth disease type 4B (CMT4B) due to mutations in Myotubularin-related proteins (MTMRs), 2019-05-27

• Myelin Abnormality in CMT4J Recapitulates Features of Acquired Demyelination, 2018-03-30

• Burst mitofusin activation reverses neuromuscular dysfunction in murine CMT2A, 2020-10-19

• MFN2 mutations in Charcot-Marie-Tooth disease alter mitochondria-associated ER membrane function but do not impair bioenergetics, 2019-01-11

• Quality-of-Life in Charcot Marie Tooth Disease: The Patient's Perspective, 2014-06-27

• Regulating PMP22 Expression as a Dosage Sensitive Neuropathy Gene, 2019-10-03

• Accelerate Clinical Trials in Charcot-Marie-Tooth Disease (ACT-CMT): A Protocol to Address Clinical Trial Readiness in CMT1A, 2022-06-27

• Natural history of Charcot-Marie-Tooth disease during childhood, 2021-07-01

• Variation inSIPA1L2Is Correlated with Phenotype Modification in Charcot- Marie- Tooth Disease Type 1A, 2020-05-06

• DEFINING DISABILITY: DEVELOPMENT AND VALIDATION OF A DISABILITY SEVERITY INDEX IN INHERITED NEUROPATHY, 2014-08-25

• Validation of the Parent-Proxy Pediatric Charcot-Marie-Tooth Disease Quality of Life Outcome Measure, 2023-02-17

• Anterior Tibialis CMAP Amplitude Correlations with Impairment in CMT1A, 2013-03-03

• Rare Manifestation of a c.290 C>T, p.Gly97GluVCPMutation, 2015-03-23

• Progressive Lower Extremity Weakness and Axonal Sensorimotor Polyneuropathy from a Mutation inKIF5A(c.611G>A;p.Arg204Gln), 2015-10-12

• Treatment with IFB-088 Improves Neuropathy in CMT1A and CMT1B Mice, 2022-04-30

• Mutation screen reveals novel variants and expands the phenotypes associated withDYNC1H1, 2015-06-24

• Absence ofDystrophin Related Protein-2disrupts Cajal bands in a patient with Charcot-Marie-Tooth disease, 2015-07-07

• Biomarkers predict outcome in Charcot Marie Tooth Disease 1A, 2017-08-31

• Psychometrics evaluation of Charcot-Marie-Tooth Neuropathy Score (CMTNSv2) second version, using Rasch analysis, 2015-01-01

• Genetic and clinical characteristics ofNEFL-related Charcot-Marie-Tooth disease, 2017-05-13

• Transitioning outcome measures: relationship between the CMTPedS and CMTNSv2 in children, adolescents and young adults with Charcot-Marie-Tooth disease, 2013-06-19

• Dynein mutations associated with hereditary motor neuropathies impair mitochondrial morphology and function with age, 2013-06-04